Skip to main content
. 2016 Apr 22;7(21):31393–31400. doi: 10.18632/oncotarget.8918

Figure 1. Kaplan–Meier survival curves and Breslow tests for IDH-1R132H mut and Ki-67≥30 in diffuse gliomas.

Figure 1

Patient were separated into groups based on IDH-1R132H mut and Ki-67 index; clinical outcomes differed among the groups a. Ki-67<30 was associated with longer overall survival in both IDH-1R132H mut b. and IDH-1R132H wt c. patients.